Mass spectrometry imaging for drug distribution studies

Brendan Prideaux, Markus Stoeckli

Research output: Contribution to journalReview article

161 Citations (Scopus)

Abstract

Since its introduction mass spectrometry imaging (MSI) has proven to be a powerful tool for the localization of molecules in biological tissues. In drug discovery and development, understanding the distribution of both drug and its metabolites is of critical importance. Traditional methods suffer from a lack of spatial information (tissue extraction followed by LCMS) or lack of specificity resulting in the inability to resolve parent drug from its metabolites (whole body autoradiography). MSI is a sensitive and label-free approach for imaging drugs and metabolites in tissues. In this article we review the different MSI technologies that have been applied to the imaging of pharmaceuticals. Recent technical advances, applications and current analytical limitations are discussed.This article is part of a Special Issue entitled: Imaging Mass Spectrometry: A User's Guide to a New Technique for Biological and Biomedical Research.

Original languageEnglish (US)
Pages (from-to)4999-5013
Number of pages15
JournalJournal of Proteomics
Volume75
Issue number16
DOIs
StatePublished - Aug 30 2012
Externally publishedYes

Fingerprint

Mass spectrometry
Mass Spectrometry
Imaging techniques
Metabolites
Pharmaceutical Preparations
Tissue
Information Storage and Retrieval
Drug Discovery
Autoradiography
Biomedical Research
Technology
Labels
Molecules

Keywords

  • DESI-MSI
  • Drug distribution
  • MALDI-MSI
  • Mass spectrometry imaging
  • SIMS-MSI

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics

Cite this

Mass spectrometry imaging for drug distribution studies. / Prideaux, Brendan; Stoeckli, Markus.

In: Journal of Proteomics, Vol. 75, No. 16, 30.08.2012, p. 4999-5013.

Research output: Contribution to journalReview article

Prideaux, Brendan ; Stoeckli, Markus. / Mass spectrometry imaging for drug distribution studies. In: Journal of Proteomics. 2012 ; Vol. 75, No. 16. pp. 4999-5013.
@article{bf81233af25d43d5bd03b2ed1e4c07b0,
title = "Mass spectrometry imaging for drug distribution studies",
abstract = "Since its introduction mass spectrometry imaging (MSI) has proven to be a powerful tool for the localization of molecules in biological tissues. In drug discovery and development, understanding the distribution of both drug and its metabolites is of critical importance. Traditional methods suffer from a lack of spatial information (tissue extraction followed by LCMS) or lack of specificity resulting in the inability to resolve parent drug from its metabolites (whole body autoradiography). MSI is a sensitive and label-free approach for imaging drugs and metabolites in tissues. In this article we review the different MSI technologies that have been applied to the imaging of pharmaceuticals. Recent technical advances, applications and current analytical limitations are discussed.This article is part of a Special Issue entitled: Imaging Mass Spectrometry: A User's Guide to a New Technique for Biological and Biomedical Research.",
keywords = "DESI-MSI, Drug distribution, MALDI-MSI, Mass spectrometry imaging, SIMS-MSI",
author = "Brendan Prideaux and Markus Stoeckli",
year = "2012",
month = "8",
day = "30",
doi = "10.1016/j.jprot.2012.07.028",
language = "English (US)",
volume = "75",
pages = "4999--5013",
journal = "Journal of Proteomics",
issn = "1874-3919",
publisher = "Elsevier",
number = "16",

}

TY - JOUR

T1 - Mass spectrometry imaging for drug distribution studies

AU - Prideaux, Brendan

AU - Stoeckli, Markus

PY - 2012/8/30

Y1 - 2012/8/30

N2 - Since its introduction mass spectrometry imaging (MSI) has proven to be a powerful tool for the localization of molecules in biological tissues. In drug discovery and development, understanding the distribution of both drug and its metabolites is of critical importance. Traditional methods suffer from a lack of spatial information (tissue extraction followed by LCMS) or lack of specificity resulting in the inability to resolve parent drug from its metabolites (whole body autoradiography). MSI is a sensitive and label-free approach for imaging drugs and metabolites in tissues. In this article we review the different MSI technologies that have been applied to the imaging of pharmaceuticals. Recent technical advances, applications and current analytical limitations are discussed.This article is part of a Special Issue entitled: Imaging Mass Spectrometry: A User's Guide to a New Technique for Biological and Biomedical Research.

AB - Since its introduction mass spectrometry imaging (MSI) has proven to be a powerful tool for the localization of molecules in biological tissues. In drug discovery and development, understanding the distribution of both drug and its metabolites is of critical importance. Traditional methods suffer from a lack of spatial information (tissue extraction followed by LCMS) or lack of specificity resulting in the inability to resolve parent drug from its metabolites (whole body autoradiography). MSI is a sensitive and label-free approach for imaging drugs and metabolites in tissues. In this article we review the different MSI technologies that have been applied to the imaging of pharmaceuticals. Recent technical advances, applications and current analytical limitations are discussed.This article is part of a Special Issue entitled: Imaging Mass Spectrometry: A User's Guide to a New Technique for Biological and Biomedical Research.

KW - DESI-MSI

KW - Drug distribution

KW - MALDI-MSI

KW - Mass spectrometry imaging

KW - SIMS-MSI

UR - http://www.scopus.com/inward/record.url?scp=84865200761&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865200761&partnerID=8YFLogxK

U2 - 10.1016/j.jprot.2012.07.028

DO - 10.1016/j.jprot.2012.07.028

M3 - Review article

VL - 75

SP - 4999

EP - 5013

JO - Journal of Proteomics

JF - Journal of Proteomics

SN - 1874-3919

IS - 16

ER -